Stress-induced Natural Killer cell ligands (NKG2DL) (NKG2DL)

Stress-induced Natural Killer cell ligands (NKG2DL) are a diverse group of cell surface glycoproteins, primarily including the MICA, MICB, and ULBP (UL16-binding protein) families, that are upregulated in response to cellular stress such as DNA damage, oxidative stress, or malignant transformation (Source: Nature Reviews Immunology, doi:10.1038/nri.2017.99). Under normal physiological conditions, these ligands are largely absent from the surface of healthy cells, but their expression serves as a critical "danger signal" that marks compromised cells for elimination (Source: PubMed, PMID: 29427415). They function by binding to the NKG2D activating receptor, which is constitutively expressed on Natural Killer (NK) cells, γδ T cells, and CD8+ T cells, thereby triggering potent cytolytic activity and proinflammatory cytokine production (Source: Science, doi:10.1126/science.aao0503). In the context of oncology, tumors frequently evade this immune surveillance mechanism by utilizing metalloproteinases, such as ADAM10 and ADAM17, to proteolytically cleave the ligands from the cell membrane (Source: Journal of Hematology & Oncology, doi:10.1186/s13045-019-0795-1). This process, known as shedding, results in high levels of soluble ligands that act as decoys, systemically downregulating NKG2D expression and impairing the anti-tumor immune response (Source: Frontiers in Immunology, doi:10.3389/fimmu.2020.00626). Therapeutic interventions currently under investigation include monoclonal antibodies designed to block the shedding of MICA/B, bispecific antibodies that engage NK cells, and Chimeric Antigen Receptor (CAR) therapies that utilize the NKG2D extracellular domain to target ligand-positive cells (Source: Nature, doi:10.1038/s41586-018-0005-0).

Other names

NKG2D ligandsMHC class I polypeptide-related sequence A/BMICA/BUL16-binding proteinsULBPRAET1 proteins

Activation of the NKG2D receptor on effector immune cells (NK cells, CD8+ T cells) through direct binding, or stabilization of ligand expression on the target cell surface by inhibiting proteolytic shedding.